Next Article in Journal
TRPV3 in Drug Development
Next Article in Special Issue
Nanosized Drug Delivery Systems in Gastrointestinal Targeting: Interactions with Microbiota
Previous Article in Journal
Targeting TRPM2 in ROS-Coupled Diseases
Previous Article in Special Issue
Polylactic Acid—Lemongrass Essential Oil Nanocapsules with Antimicrobial Properties
Article Menu

Export Article

Open AccessArticle
Pharmaceuticals 2016, 9(3), 54; doi:10.3390/ph9030054

Preparation of Temozolomide-Loaded Nanoparticles for Glioblastoma Multiforme Targeting—Ideal Versus Reality

1
School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor 47500, Malaysia
2
Department of Pharmaceutical Chemistry, School of Pharmacy, International Medical University, Kuala Lumpur 57000, Malaysia
*
Author to whom correspondence should be addressed.
Academic Editors: Alexandru Mihai Grumezescu and Vladimir P. Torchilin
Received: 13 July 2016 / Revised: 15 August 2016 / Accepted: 24 August 2016 / Published: 8 September 2016
(This article belongs to the Special Issue Nanobiotechnology in Medicinal Chemistry)
View Full-Text   |   Download PDF [985 KB, uploaded 8 September 2016]   |  

Abstract

Temozolomide (TMZ) is one of the most effective chemotherapeutic agents for glioblastoma multiforme, but the required high administration dose is accompanied by side effects. To overcome this problem and to further improve TMZ’s efficacy, targeted delivery of TMZ by using polymeric nanoparticles has been explored. We synthesised the PLGA-PEG-FOL copolymer and attempted encapsulation of TMZ into PLGA-PEG-FOL nanoparticles using the emulsion solvent evaporation method and the nanoprecipitation method. Conjugation of PEG and FOL to PLGA has been reported to be able to increase the delivery of TMZ to the brain as well as targeting the glioma cells. However, despite making numerous modifications to these methods, the loading of TMZ in the nanoparticles only ranged between 0.2% and 2%, and the nanoparticles were between 400 nm and 600 nm in size after freeze-drying. We proceed with determining the release profile of TMZ in phosphate buffered saline (PBS). Our initial data indicated that TMZ was slowly released from the nanoparticles. The metabolite of TMZ rather than the parent compound was detected in PBS. Our study suggests that while PLGA-PEG-FOL can be used as a polymeric or encapsulation material for central delivery of TMZ, a practical and cost effective formulation method is still far from reach. View Full-Text
Keywords: glioblastoma; polymeric nanoparticles; sustained release; targeted delivery; temozolomide glioblastoma; polymeric nanoparticles; sustained release; targeted delivery; temozolomide
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Lee, C.Y.; Ooi, I.H. Preparation of Temozolomide-Loaded Nanoparticles for Glioblastoma Multiforme Targeting—Ideal Versus Reality. Pharmaceuticals 2016, 9, 54.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top